The Cooper Companies, Inc. (NASDAQ:COO) Receives $117.00 Consensus Price Target from Analysts

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twelve analysts that are presently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $117.00.

Several research analysts recently commented on COO shares. Morgan Stanley reduced their price target on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Friday, December 6th. Robert W. Baird raised their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an "outperform" rating in a research report on Thursday, August 29th. Citigroup lowered their price target on Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a report on Friday, December 6th. Piper Sandler raised their price objective on Cooper Companies from $115.00 to $120.00 and gave the stock an "overweight" rating in a report on Thursday, August 29th. Finally, Wells Fargo & Company lifted their target price on Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, December 6th.

Cooper Companies Trading Down 1.9 %

Shares of NASDAQ:COO traded down $1.87 during trading hours on Friday, hitting $94.85. 1,779,826 shares of the company's stock traded hands, compared to its average volume of 1,163,765. The firm has a market capitalization of $18.93 billion, a P/E ratio of 48.64, a price-to-earnings-growth ratio of 2.52 and a beta of 0.97. The business has a fifty day moving average price of $103.49 and a 200-day moving average price of $98.97. Cooper Companies has a 1 year low of $84.76 and a 1 year high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.03 billion. During the same quarter in the previous year, the business earned $0.87 EPS. Cooper Companies's revenue was up 9.8% compared to the same quarter last year. Equities analysts expect that Cooper Companies will post 3.98 earnings per share for the current year.

Insider Buying and Selling

In other Cooper Companies news, CEO Albert G. White III sold 114,992 shares of the firm's stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the sale, the chief executive officer now directly owns 165,273 shares in the company, valued at $18,267,624.69. This trade represents a 41.03 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.00% of the stock is currently owned by company insiders.

Institutional Trading of Cooper Companies

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Lord Abbett & CO. LLC increased its holdings in shares of Cooper Companies by 6.3% during the third quarter. Lord Abbett & CO. LLC now owns 251,402 shares of the medical device company's stock valued at $27,740,000 after acquiring an additional 14,957 shares in the last quarter. Franklin Resources Inc. increased its stake in shares of Cooper Companies by 194.0% in the third quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company's stock worth $5,265,000 after acquiring an additional 32,260 shares during the period. Synovus Financial Corp raised its holdings in shares of Cooper Companies by 18.8% during the third quarter. Synovus Financial Corp now owns 31,568 shares of the medical device company's stock worth $3,483,000 after purchasing an additional 4,987 shares during the last quarter. Tidal Investments LLC lifted its position in Cooper Companies by 7.8% during the third quarter. Tidal Investments LLC now owns 14,369 shares of the medical device company's stock valued at $1,585,000 after purchasing an additional 1,043 shares during the period. Finally, Wilmington Savings Fund Society FSB acquired a new position in Cooper Companies during the third quarter valued at $1,150,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.